KR870000231B1 - Process for preparing 2,6-pyridine methanol bis (3,4,5,-trimethoxy benzoate) - Google Patents

Process for preparing 2,6-pyridine methanol bis (3,4,5,-trimethoxy benzoate) Download PDF

Info

Publication number
KR870000231B1
KR870000231B1 KR8202547A KR820002547A KR870000231B1 KR 870000231 B1 KR870000231 B1 KR 870000231B1 KR 8202547 A KR8202547 A KR 8202547A KR 820002547 A KR820002547 A KR 820002547A KR 870000231 B1 KR870000231 B1 KR 870000231B1
Authority
KR
South Korea
Prior art keywords
bis
pyridinedimethanol
cholesterol
trimethoxybenzoate
preparing
Prior art date
Application number
KR8202547A
Other languages
Korean (ko)
Other versions
KR840000495A (en
Inventor
마리아 베드릴라 베이트 다그마르
Original Assignee
후앙 빨로 메스 까스띨로
프로데스 에스 에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후앙 빨로 메스 까스띨로, 프로데스 에스 에이 filed Critical 후앙 빨로 메스 까스띨로
Publication of KR840000495A publication Critical patent/KR840000495A/en
Application granted granted Critical
Publication of KR870000231B1 publication Critical patent/KR870000231B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The title compds. (I) were prepd. by the reaction of 2,6pyridinemethanol(II) and 3,4,5-trimethoxy benzoic acid ester in the presence of base. Thus, 6.95kg 2,6-pyridinedimethanol and 339g NaH were reacted with 26.4286Kg 3,4,5-trimethoxy benzoic acid ester at 160≰C for 6hr to give 19.4kg 2,6-pyridinedimethanol bis (3,4,5- trimethoxybenzoate) (73% yield).

Description

2, 6-피리딘디메탄올 비스(3, 4, 5-트리메톡시벤조에이트)의 제조방법Method for preparing 2,6-pyridinedimethanol bis (3, 4, 5-trimethoxybenzoate)

본 발명은 신규한 하기식의 2, 6-피러딘다메탄올 비스(3, 4, 5-트리메톡시벤조에이트)의 제조방법에 관한것이다.The present invention relates to a process for producing the novel 2, 6-pyridinethanol bis (3, 4, 5-trimethoxybenzoate) of the following formula.

Figure kpo00001
Figure kpo00001

상기 반응은 하기 도표에서와 같이 염기 존재하 2, 6-피리딘디메탄올을 3, 4, 5-트리메톡시벤조산과 반응시키는 것에 의한 에스테르 교환반응으로 구성된다.The reaction consists of a transesterification reaction by reacting 2, 6-pyridinedimethanol with 3, 4, 5-trimethoxybenzoic acid in the presence of a base as shown in the table below.

Figure kpo00002
Figure kpo00002

원료물질, 즉 3, 4, 5-트리메톡시멘조산의 에스테르류로는 문헌에 기재되어 있는 것과 같은 분자량이 작은 알킬에스테르류를 사용하는 것이 바람직하다.As esters of the raw material, ie, 3, 4, 5-trimethoxymentoic acid, it is preferable to use alkyl esters having a small molecular weight as described in the literature.

반응은 용매부재하 수행된다. 2, 6-피리딘디메탄을의 1몰당 2.2몰의 에스테르가 사용된다. 염기로는 수소화나트륨이 사용된다. 보통 촉매가 충분량 존재하는 경우에도 염기의 양을 과량 즉, 2, 6-피리딘디메탄올에 대해 100∼200몰을 사용함으로써 반응을 신속히 진행시킬 수가 있다.The reaction is carried out in the absence of solvent. 2.2 moles of ester per mole of 2, 6-pyridinedimethane are used. Sodium hydride is used as the base. Usually, even when a sufficient amount of catalyst is present, the reaction can be rapidly advanced by using an excess amount of base, that is, 100 to 200 moles with respect to 2,6-pyridinedimethanol.

이 반응은 2단계에 걸쳐서 진행된다. 제1단계에서는 2, 6-피리딘디메탄올이 상응 알코올레이트로 부분적으로 변형된다. 이때의 적당한 외부 온도는 약 130℃이다. 그런 다음 수득된 반응물질에 3, 4, 5-트리메톡시벤조산의 알킬에스테르를 가하고, 에스테르 교환반응을 수행한다. 이때의 적당한 외부온도는 160°∼170℃이다. 생성된 알코올을 표준 압력하(바람직하게는 진공에서), 증류 제거시킴으로써 반응 물질이 심하게 탁해지는 것을 방지시킨다.This reaction proceeds in two steps. In the first step, 2, 6-pyridinedimethanol is partially modified with the corresponding alcoholate. Appropriate external temperature at this time is about 130 degreeC. Then, an alkyl ester of 3, 4, 5-trimethoxybenzoic acid is added to the obtained reactant, and a transesterification reaction is carried out. Suitable external temperature at this time is 160 degreeC-170 degreeC. The resulting alcohol is distilled off under standard pressure (preferably in vacuo) to prevent severe reaction of the reaction mass.

가열시간은 6∼12 시간이다.The heating time is 6 to 12 hours.

상기의 결과로서 2, 6-피리딘디에탄올 비스(3, 4, 5-트리메톡시벤조에이트)가 70∼90%의 고순도로 수득된다. 이 물질의 구즈는 핵자기 공명스펙트럼 및 적외선 스펙트럼검사에 의해 확인되어 있다.As a result of this, 2, 6-pyridine diethanol bis (3, 4, 5-trimethoxybenzoate) is obtained with high purity of 70 to 90%. The goose of this material has been confirmed by nuclear magnetic resonance spectra and infrared spectroscopy.

본원 발명에 의한 상기의 방법은 공업적으로 대량 생산이 용이하고 여떤 종류의 불순물로부터도 최종생성물을 분리시킬 수 있다는 점을 특징으로 한다. 또한 2, 6-피리딘디메탄올 비스(3, 4, 5-트리메톡시벤조에이트)는 유리한 약리 작용을 가지고 있다.The above method according to the present invention is characterized in that industrial mass production is easy and the final product can be separated from any kind of impurities. In addition, 2, 6-pyridinedimethanol bis (3, 4, 5-trimethoxybenzoate) has an advantageous pharmacological action.

죽종 유발 음식물을 토끼에 투여하여 발생시킨 과지방혈증 및 동맥경화증에 대한 2, 6-피리딘디메탄올 비스(3, 4, 5-트리메톡시비조에이트)의 작용을 테스트한다. 2, 6-피리딘디메탄올 비스(3, 4, 5-트리메톡시벤조에이트)를 1군의 동물에 50mg/kg/day의 양으로 12주동안 경구 투여시키고, 또 다른 동물군에는 비처리된 상기의 음식물을 투여시킨다(대조군).The effect of 2, 6-pyridinedimethanol bis (3, 4, 5-trimethoxybiszoate) on hyperlipidemia and atherosclerosis caused by administration of atheromatous foods to rabbits is tested. 2, 6-pyridinedimethanol bis (3, 4, 5-trimethoxybenzoate) was orally administered to one group of animals at an amount of 50 mg / kg / day for 12 weeks and another group was untreated. The above food is administered (control).

상기 두군에서 다음과 같은 것을 측정한다.The following two groups are measured.

죽증 치료작용 : 대동맥부위 및 관라이트(light)에 있어서의 병변(lesions)의 확대, 유리 콜레스테롤/에스테르화된 콜레스테롤의 관계 및 대동맥벽의 콜레스테롤의 함량.Treatment of Atherosclerosis: Enlargement of lesions in the aortic site and light, relationship of free cholesterol / esterified cholesterol and cholesterol content in the aortic wall.

콜레스테롤혈 저하작용 : 세릭(seric)콜레스테롤의 전체비율, LDL-콜레스테롤의 정도 및 HDL/LDL콜레스테롤의 관계.Cholesterol-lowering effect: Relationship between total ratio of seric cholesterol, degree of LDL-cholesterol and HDL / LDL cholesterol.

상기에서 수득된 결과를 하기표에 요약 기재한다.The results obtained above are summarized in the table below.

2, 6-피라딘디메탄올 비스(3, 4, 5-트리메톡시벤조에이트)는 죽종 유발 음식물에 의한 대동맥부의 및 관라이트의 감염율을 각각 24.6% 및 48.6%씩 경감시키는 죽종 치료제로서의 괄목할만한 활성을 나타낸다. 또한 이것은 대조군에서 수득된 값에 비해 총대동맥 콜레스테롤을 21.2% 경감시키는 강력한 경감작용을 나타낸다. 2, 6-피리딘디 메탄올 비스(3, 4, 5-트리메톡시벤조에이트)는 유리 콜레스테롤/에스테르화 콜레스테롤의 관계를 166%만큼 증가시키고, 21.2%라는 경감율에 따라 혈관벽의 콜레스테롤 예스테라아제에 대한 매우 바람직한 약리작용을 나타낸다.2, 6-pyridindimethanol bis (3, 4, 5-trimethoxybenzoate) is a remarkable activity as a therapeutic agent for atherosclerosis which reduces the infection rate of aortic part and tubelite by 24.6% and 48.6%, respectively Indicates. It also shows a potent alleviation of 21.2% of total aortic cholesterol compared to the values obtained in the control group. 2, 6-pyridinedi methanolic bis (3, 4, 5-trimethoxybenzoate) increases the relationship of free cholesterol / esterified cholesterol by 166% and cholesterol lowering of blood vessel walls with a 21.2% reduction rate Very preferred pharmacological action against.

2, 6-피러딘디메탄올 비스(3, 4, 5-트리메톡시벤조에이트)는 총 세릭 콜레스테롤을 32.4%만큼, LDL-콜레스테롤비율(B콜레스테 롤)을 37.9%만큼 경감시킨다.2, 6-pyridindimethanol bis (3, 4, 5-trimethoxybenzoate) reduces the total ceric cholesterol by 32.4% and LDL-cholesterol ratio (B cholesterol) by 37.9%.

이에 따라 HDL/LDL-콜레스테롤간의 관계는 52%만큼 증가되는데, LDL-콜레스테롤율의 현저한 감소의 결과로서 비정상적으로 큰 값이 수득된다.This increases the relationship between HDL / LDL-cholesterol by 52%, resulting in unusually large values as a result of the significant decrease in LDL-cholesterol rate.

본 방법을 더 설명키 위해, 하기의 실시예를 실제로 나타낸다. 이것으로 본 발명의 범위가 제한되는 것은 아니다.To further illustrate the method, the following examples are actually shown. This does not limit the scope of the present invention.

죽종유 발음식물을 토끼에 투여시킨 경우의 2, 6-피리딘디메탄을 비스(3, 4, 5-트리메톡시벤조에이트) (50mg/kg p.o.)의 콜레스테롤저하 및 죽종치유작용(동일한 음식물을 투여시킨 비처리군의 결과와 비교하여).When 2, 6-pyridine dimethane was administered to rabbits with bamboo oil-producing plants, bis (3, 4, 5-trimethoxybenzoate) (50 mg / kg po) lowered cholesterol and hemorrhage (same food) Compared to the results of the untreated group administered).

Figure kpo00003
Figure kpo00003

[실시예 1]Example 1

6.95789(50몰)의 2, 6-피리딘디메탄올 및 339g의 NaH(파라핀중의 약 50%: 7.06몰)의 혼합물을 1시간동안 130℃로 가열시킨다. 균일 물질을 수득하여, 여기에 26.4286kg(110몰)의 3, 4, 5-트리메톡시벤조산의 에틸에스테르를 가한다. 14mmHg의 진공하 이를 6시간 동안 160℃로 가열한다. 가열후 실온으로 냉각시킨 다음 120ml의 이소프로판올 및 20ml의 물을 상기의 불투명 물질에 가한다. 침전물을 여과시키고, 물 및 이소프로판올을 차례로 사용하여 세척시킨다. 이에 따라 융점이 110∼122℃인 2, 6-피리딘디메탄올 비스(3, 4, 5-트리메톡시벤조에이트) 19.4kg(36.7몰: 73%)이 수득된다. 아세토니트릴로 결정화시켜 융점이 127~8℃인 시료를 수득한다.A mixture of 6.95789 (50 moles) of 2, 6-pyridinedimethanol and 339 g of NaH (about 50% in paraffin: 7.06 moles) is heated to 130 ° C. for 1 hour. To obtain a homogeneous substance, 26.4286 kg (110 mol) of ethyl ester of 3, 4, 5-trimethoxybenzoic acid are added thereto. Vacuum at 14 mm Hg and heat it to 160 ° C. for 6 hours. After heating to room temperature, 120 ml of isopropanol and 20 ml of water are added to the opaque material. The precipitate is filtered off and washed with water and isopropanol in turn. This gave 19.4 kg (36.7 mol: 73%) of 2, 6-pyridinedimethanol bis (3, 4, 5-trimethoxybenzoate) having a melting point of 110 to 122 ° C. Crystallization with acetonitrile gives a sample having a melting point of 127-8 ° C.

계산치 : (C27H29NO10) : 61.47%C 5.54%H 2.65%NCalculated Value: (C 27 H 29 NO 10 ): 61.47% C 5.54% H 2.65% N

실측치 : 61.58%C 5.71%H 2.79%NFound: 61.58% C 5.71% H 2.79% N

[실시예 2]Example 2

6.9578kg(50몰)의 2, 6-피리딘디메탄올 및 339g의 NaH(파라핀 중의 약 50%:7.06 몰)의 혼합물을 실시예 1과 동일한 방법으로 처리한다. 수득된 균일물질에 3, 4, 5-트리메톡시벤조산의 메틸에스테르 24.8856kg(110몰)을 가한다.14mmHg의 진공하, 이를 7시간 동안 160℃로 가열시킨다. 반응 혼합물을 이소프로판올/물로 결정화시켜 융점이 126∼8℃인 피리딘-2, 6-디메탄올의 비스-(3, 4, 5-트리메톡시벤조에이트) 23.74kg(45 몰 : 90%)이 수득된다.A mixture of 6.9578 kg (50 moles) of 2, 6-pyridinedimethanol and 339 g of NaH (about 50%: 7.06 moles in paraffin) is treated in the same manner as in Example 1. 24.8856 kg (110 mol) of methyl ester of 3, 4, 5-trimethoxybenzoic acid are added to the homogeneous material obtained. Under vacuum of 14 mmHg, it is heated to 160 ° C. for 7 hours. The reaction mixture was crystallized with isopropanol / water to give 23.74 kg (45 mol: 90%) of bis- (3, 4, 5-trimethoxybenzoate) of pyridine-2, 6-dimethanol having a melting point of 126-8 ° C. do.

Claims (4)

하기 일반식(2)의 2, 6-피리딘디메탄을을 염기 존재하에 하기 일반식(3)의 3, 4, 5-트리메톡시 벤조산 에스테르와 반응시켜 에스테르 교환반응 시킴을 특징으로 하는 하기 일반식(A)의 2, 6-피리딘디메탄올 비스(3, 4, 5-트리메톡시 벤조에이트)의 제조방법.2, 6-pyridinedimethane of formula (2) is reacted with 3, 4, 5-trimethoxy benzoic acid ester of formula (3) in the presence of a base to undergo transesterification. A process for producing 2, 6-pyridinedimethanol bis (3, 4, 5-trimethoxy benzoate) of formula (A).
Figure kpo00004
Figure kpo00004
제1항에 있어서, 3, 4, 5-트리메톡시벤조산 에스테르류로서 분자량이 작은 알킬에스테르류를 사용함을 특징으로 하는 방법.The method according to claim 1, wherein alkyl esters having a low molecular weight are used as the 3, 4, 5-trimethoxybenzoic acid esters. 제1항에 있어서, 수소화나트륨을 염기성 촉매로 사용함을 특징으로 하는 방법.The process of claim 1 wherein sodium hydride is used as the basic catalyst. 제1항에 있어서, 생성된 알코올을 증류 제거시킴으로써 에스테르 교환반응을 수행함을 특징으로 하는 방법.The process according to claim 1, wherein the transesterification is carried out by distilling off the alcohol produced.
KR8202547A 1982-03-01 1982-06-08 Process for preparing 2,6-pyridine methanol bis (3,4,5,-trimethoxy benzoate) KR870000231B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES510001A ES8307750A1 (en) 1982-03-01 1982-03-01 2,6-Pyridine di:methanol bis(3,4,5-trimethoxybenzoate) prepn.
ES510,001 1982-03-01
ES510001 1982-03-01

Publications (2)

Publication Number Publication Date
KR840000495A KR840000495A (en) 1984-02-22
KR870000231B1 true KR870000231B1 (en) 1987-02-18

Family

ID=8483740

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8202547A KR870000231B1 (en) 1982-03-01 1982-06-08 Process for preparing 2,6-pyridine methanol bis (3,4,5,-trimethoxy benzoate)

Country Status (6)

Country Link
KR (1) KR870000231B1 (en)
ES (1) ES8307750A1 (en)
FI (1) FI821796A0 (en)
IN (1) IN159364B (en)
YU (1) YU43267B (en)
ZA (1) ZA825637B (en)

Also Published As

Publication number Publication date
ES510001A0 (en) 1983-07-16
ZA825637B (en) 1983-09-28
KR840000495A (en) 1984-02-22
YU43267B (en) 1989-06-30
IN159364B (en) 1987-05-09
ES8307750A1 (en) 1983-07-16
FI821796A0 (en) 1982-05-20
YU117582A (en) 1985-03-20

Similar Documents

Publication Publication Date Title
US4544750A (en) Certain pyridyl-N-oxide intermediates for the preparation of omeprazole
US4391995A (en) 4-Phenoxy-phenoxy-alkane-carboxylic acid derivatives and process for their manufacture
US4658055A (en) Method for manufacture of 7-(2,5-dioxocyclopentyl)heptanoic acid derivative
EP0079447A1 (en) Deazapurine derivatives
KR870000231B1 (en) Process for preparing 2,6-pyridine methanol bis (3,4,5,-trimethoxy benzoate)
EP0300056B1 (en) Process for preparing tetrakis (3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl)methane
JPS6319499B2 (en)
US3325515A (en) Coumarin derivatives and their preparation
US4278678A (en) Substituted oxy-cyclohexylacetic acid derivatives
CA1152087A (en) Aryl-substituted furanes, and process for their production
SU1709903A3 (en) Method for the synthesis of 4-chloro-3-(c-c)-alkoxy- 2betenoic acid @@@-alkyl ester
CN108424383B (en) Preparation method of curcumin nicotinate
US5189202A (en) Process for the preparation of 3,3-dimethyl-4-pentenoic acid
JPH0137397B2 (en)
US4008256A (en) Esterification of furfuryl alcohol and its derivates
US4249015A (en) Preparation of organic acids and/or esters
US4922000A (en) Production of dialkyl (phenylenedioxy) diacetates
SU1046240A1 (en) Process for preparing ethers of beta-alkoxyacrylic or beta-alkoxymethacrylic acid
AU4650196A (en) Method for the preparation of pure carboxyethyl germanium sesquioxide
JP2810747B2 (en) Method for producing pyridine derivative
JPS61118348A (en) Manufacture of hydroxymethylenealkoxyacetic acid ester
KR900007512B1 (en) Process for the preparation of 3,3-dimethyl-4-pentenoic acid
EP0074837A1 (en) 4-Substituted pyridine catalysts
KR840000369B1 (en) Process for preparation of 2-isopropylamino pyrimidine
SU1468412A3 (en) Method of producing alkyl ethers of 4-alkoxy-3-pyrrolin-2-on-1-yl acetic acid